Anar Dossa BScPharm Pharm D CDE
Director, Pharmacy Services
Pacific Blue Cross | Dr. Kerri Novak MD MSc FRCPC
Clinical Associate Professor of Medicine, Division of Gastroenterology and Hepatology
University of Calagary
| Chris Bonnett, MHSc, PhD
Principal Consultant, H3 Consulting |
Anar Dossa is the Director of Pharmacy Services at Pacific Blue Cross. She has over 30 years of experience in applying evidence informed decisions into daily practice. She is currently the Chair of the Prescription Drug Committee, CLHIA, Clinical Assistant Professor in the Faculty of Pharmaceutical Sciences at UBC, and Past Chair, College of Pharmacists of BC. | Dr. Novak is an academic gastroenterologist at the University of Calgary with a special interest in small bowel imaging using ultrasound in inflammatory bowel disease. Inspired while working in gastrointestinal radiology in Calgary, Dr. Kerri Novak, MD, pursued training in intestinal ultrasound (IUS) in Germany in 2012. She returned to Calgary to establish the first inflammatory bowel disease (IBD) clinic in Canada to provide routine IUS for patients with IBD. She is the Deputy Division head, Division of Gastroenterology and Hepatology and is the Medical Lead of Quality Improvement at the University of Calgary. Kerri is passionate about improving the health system, and ensuring patients are heard and recognized to make the journey in their path to health better. | Chris Bonnett established H3 Consulting in 1999, after 18 years of progressive experience in underwriting, reinsuring, selling, and marketing employee benefits. He provides practical prescription drug policy research for private and public drug plan leaders, and consults on workplace health strategy. He speaks and writes frequently on these topics. Chris has been a volunteer director on the Boards of four health organizations. He is a sessional Professor in workplace health at Humber College, and is on the Advisory Board of the Sanofi Canada Healthcare Survey. He holds a Master's degree in Health Science from the University of Toronto, and a PhD in drug policy from the University of Waterloo. |